chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021)/the number of days that have passed were 11; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021)/the number of days that have passed were 11) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021)/the number of days that have passed were 11). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021)/the number of days that have passed were 11) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
chills really badly for 24 hrs; felt tired & fatigued.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills really badly for 24 hrs) and FATIGUE (felt tired & fatigued.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021 at 3:15 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced CHILLS (chills really badly for 24 hrs). 27-Mar-2021, the patient experienced FATIGUE (felt tired & fatigued.). At the time of the report, CHILLS (chills really badly for 24 hrs) and FATIGUE (felt tired & fatigued.) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.
This spontaneous prospective pregnancy report was received from a 25 years old female consumer concerning her. The patient had none pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies. On 12-MAY-2016 the patient was vaccinated with her second dose of unidentified Merck hpv vaccine (name and lot number not provided), intramuscular. On the next day, the patient found that she was pregnant. No other symptoms were reported. The last menstrual period and estimated delivery date were not reported. The patient did not seek medical attention, no treatment was given for the event and none laboratory diagnostic studies were performed. At the time of reporting, the patient was 2-3 weeks pregnant. The pregnancy outcome was pending. Additional information is not expected as the reporter did not wish further contact.
Patient is a 21-year-old who received her first Anthrax and primary Smallpox vaccination on 22 January 2004.  She demonstrates that she received her Anthrax in the LEFT tricep and Smallpox vaccination in her RIGHT deltoid.  She initially reports mild swelling and pain at each injection site but no substantial swelling or erythema occurring 7-10 days after her vaccinations.  Approximately 1 to 1 ½ weeks after immunizations, upon waking she noticed mild swelling in both her hands and wrists that ached with movement.  Associated symptoms included axillary lymphandenopathy, left greater than right, stiffness in neck, posteriorly and laterally, and difficulty removing rings from her hands. She was given her second Anthrax vaccination on 23Jan04. She again demonstrates vaccine given in the right tricep. Her previous symptoms persisted causing her to report to sick call on 2 February 2004 where she was advised that she was experiencing a mild reaction to immunizations and was prescribed Indocin 25mg 1-2 every 12 hours.    Her symptoms continued as a constant ache that never stopped.  The ache varied in intensity from 3-4/10 to 7/10 (today).  Movement, lifting, prolonged use of hands and arms triggers feelings of weakness, numbness and tingling that reportedly extended to her elbows, limiting her ability to work on board ship.  She was medi-vaced for further evaluation and treatment.
Fever (8 hrs), fatigue (24 hours), malaise (12 hours), sore arm (12 hours), body pain (24 hours)
I had no adverse reaction to the vaccine; I feel like I would have been much sicker if I had not been vaccinated. I kept testing negative for Covid but my fever will not go away. They thought it was a breakthrough case of Covid. They treated me with monoclonal antibodies and high doses of vitamins. I was better in 4 days.
Information has been received concerning a female who was recently vaccinated and subsequently, the pt complained of swelling, sore, and erythema at injection site. In follow up, the pt's experience was described as unknown. The pt recovered 7 days post vaccination. the pharmacist would like lot # checked for recall or irregularities. The records of testing prior to release of this lot have been checked by Biological Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biological Evaluation and Research and was released.
fell asleep in waiting room p/inject given slept for 3 days, only getting up 4-5 hrs for about 5 min to take a bottle; woke on own but not alert; mom unable to keep awake;
Night after the shot, I had an extremely bad headache. The following day the headache persisted until 5 PM. I also was fatigued and unable to do any work due to headache. Five days later, on May 11 I had similar symptoms, So I left work.
Morning after second injection, presented with oral vesicles and palatal petechial rash. No systemic symptoms or other rash. Will follow. No tests required yet.
14 days to date after vac. pt went into sleasers; hosp 2 days; had been sick for a full year after; still has seemus;
Synopsis: 29 y.o. male w hx myocarditis of unknown etiology in September of this year presenting w six days of palpitations - a sx he associates w prior myocarditis. No CP or SOB. No dizziness. No weight gain. Had second COVID vaccine 5/12/21 and sxs began within a day or two following. Seen in rapid care and found to have tropinemia. Spoke w cardiology who requested an echo, motrin  (confirmed w pharmacy), colchicine, and planned an echo. Reeval to follow - if trop downtrending, may be able to go. He would prefer discharge.  29yo patient with history of depression, OCD, who was admitted 8/2020 with chest pain for 2 weeks found to have episode of myopericarditis with troponin T peak 0.95 and Troponin I of 6.35. CRP was 14. At the time TTE showed LVEF 50%. He was treated with lisinopril and ibuprofen and had improvement of pain. He later followed with a cardiac MRI 9/2020 which showed LVEF 55% and patchy epicardial/midmyocardial enhancement consistent with myocarditis. Trace pleural effusion.   Patient was called by his cardiolgist today. He reported he has been feeling unwell for past 5 days (similar symptoms to his first moderna shot) after his moderna shot #2. He had fatigue, body aches, chest pain, back pain and feelings of palpitations. He had some mild fevers and chills initially as well. These symptoms also occurred when he had moderna #1 (exact same). He was asked by cardiologist to come to the ED concerning for myocarditis given reports of myocarditis post vaccination.   Upon arrival to the ED, patients vitals were stable. He does not have any chest pain at this time. He reports that he had some palpitations starting after his shot. He denies any SOB, nausea, vomiting at this time.   His HR was 60s in the ED with sBP 120s/67 on room air.  His CRP was normal 2.8 Troponin I POC 1.66 EKG without any significant changes from prior but slightly more accentuates TWI in leads II, AVR.  29 y.o. male w hx myocarditis of unknown etiology in September of this year presenting w six days of palpitations - a sx he associates w prior myocarditis. No CP or SOB. No dizziness. No weight gain. Had second COVID vaccine 5/12/21 and sxs began within a day or two following. Seen in rapid care and found to have tropinemia. Spoke w cardiology who requested an echo, motrin  (confirmed w pharmacy), colchicine, and planned an echo. Reeval to follow - if trop downtrending, may be able to go. He would prefer discharge.
Vaccine had stored at room temperature; Possibly expired dose administered; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Possibly expired dose administered) and PRODUCT STORAGE ERROR (Vaccine had stored at room temperature) in a 23-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Possibly expired dose administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine had stored at room temperature). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Possibly expired dose administered) and PRODUCT STORAGE ERROR (Vaccine had stored at room temperature) outcome was unknown.            Patient was not on any concomitant medications. Patient reports she not been experiencing side effects as of yet. No treatment medication was reported.
While I had several seemingly minor and/or expected symptoms, I want to emphasize the extreme fatigue and brain fog that lasted 17 days, and greatly effected my ability to function in daily life.  June 4-8:  Mild fatigue and brain fog. June 9-11: Increased severity of brain fog/ mental cloudy-ness and decreased cognition.  I was unable to get my head right and focus and stay on task.  I needed to lay down and sleep. June 12 - In addition to my mental cloudy-ness and decreased cognition I lost sensation to the left side of my face.  I felt numb, although I still had feeling  and  muscle control. June 13-15 - Regained sensation in face, had tight jaw, still extreme fatigue and brain-fog.  Slept all day. June 15-17 - Fatigue and decreased cognition continued. June 18-21 - Experienced moments clarity throughout the day June 22-26(today) - Felt like myself again
MUSCLE SPASMS IN BACK; HIP PAIN; EXHAUSTION; LIGHT HEADACHE; DIFFICULT TIME FALLING ASLEEP; VERY RESTLESS; This spontaneous report received from a patient concerned a 31 year old female. The patient's weight was not reported and height was 162.56 centimeters. The patient's past medical history included reaction to vaccine, and other pre-existing medical conditions included patient weight v1 118. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 15:45 for prophylactic vaccination. No concomitant medications were reported.  On 10-MAR-2021 23:00, the subject experienced very restless. On 10-MAR-2021 23:00, the subject experienced difficult time falling asleep. On 11-MAR-2021, the subject experienced muscle spasms in back. On 11-MAR-2021, the subject experienced hip pain. On 11-MAR-2021, the subject experienced exhaustion. On 11-MAR-2021, the subject experienced light headache. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from very restless, muscle spasms in back, difficult time falling asleep, hip pain, and light headache on 11-MAR-2021, and had not recovered from exhaustion. This report was non-serious.
Within a minute or less of receiving the shot, I experienced a rapid and intense onset of blurred vision, lightheadedness, profuse sweating, and extreme numbness all over but especially in my hands and feet. I came close to losing consciousness and was instructed to lay down with my knees bent to increase blood flow. I slowly came to over the course of probably 10 minutes while laying on the ground, but my hands and especially my fingers remained numb for 30-45 minutes while I experienced chills. My left hand and fingers were extremely pale and bluish during this time. I also had minor pains on the left side of my neck and left shoulder blade. Color came back to my left hand and chills subsided around an hour after my shot.
Information has been received from a registered nurse concerning a patient who on 13-DEC-1999 was vaccinated with a dose of Varivax. Subsequently, in March 2006, the patient developed breakthrough varicella. Unspecified medical attention was sought. Thee was no product quality complaint. No additional information is expected.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 20-NOV-2015 the patient was vaccinated with improperly stored MMR II (dose and route not reported, lot # L024264, expiration date: 01-JUL-2017). No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
This is a spontaneous report from a Pfizer sponsored program from a contactable consumer (patient). A patient of unspecified age, ethnicity and gender received PREVNAR 13, via an unspecified route of administration on an unspecified date as single dose for immunization.  The patient's medical history and concomitant medications were not reported. The patient hurt for 2 days on an unspecified date. The outcome of hurt for 2 days was unknown. No follow-up attempts are possible. No further information is expected.
Felt numbing/tingling on and around lips. Lasted about 30 minutes then went away
I got the normal muscle aches, pain, fatigue, fever (103),and headache. I had on Sunday, the day after I had pain under my left rib toward my side, leg and groin. I had developed red spots on my legs. I contacted my PCP and they sent my platelet test and it can back ok. I went in to see my PCP and he checked me and only thing he came up with  due to my auto immune disease it triggered inflammation.  I'm still in pain everywhere and can't touch certain parts of my body, my Dr. can't figure out where it's from and believes it's from the shot. If it's not better in a week he wants me to go back.
This case was reported by a healthcare professional and described the occurrence of injection site pain in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On 7 October 2011 at 15:00 the subject received a dose of FLULAVAL (details unknown). On an unspecified date in October 2011, less than one week after vaccination with FLULAVAL, the subject experienced injection site pain. At the time of reporting the outcome of the event was unspecified. The healthcare professional reported that 5 subjects had received FLULAVAL and had experienced injection site pain. This is case 3 of 5 (see case IDs A0949586A, A0949593A, A0949595A, A0949596A for details of the other reports).
Information has been received from a female nurse practitioner of unknown age referring to herself. There was no information about the patient's medical history and concurrent condition. On 28-SEP-2015, the patient was vaccinated with a dose of improperly stored ZOSTAVAX vial 19400 plaque-forming unit (PFU) (lot # K026365, expiration date: 15-MAR-2016, dose and route unknown) (incorrect product storage). There was no information about concomitant therapy. No adverse effects were reported. Additional information has been requested.
patient called and said she started having sore and swollen arm after receiving shingirx on 04/14/23. Informed patient these are listed as side effects and suggested to the patient to take some antihistamine (benadryl, zyrtec, claritin) to help with the inflammation.
This spontaneous report received from a licensed practical nurse refers to two unspecified patients of unknown age and gender who on unknown dates were vaccinated with two improperly stored doses of VARIVAX (Merck) (dose, lot #, expiration date and route of administration were not reported). No adverse effects reported. It was unknown if the patients sought medical attention. Product quality complain (PQC) was not involved. Follow up information has been received on 05-MAR-2015 from a licensed practical nurse refers to a female patient of unknown age. On 26-JAN-2015, the patient was vaccinated with a dose of VARIVAX (Merck) (lot # K009758, expiration date 26-JAN-2016) that had experienced a temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a Medical Assistant referring to an unknown number of patients of unknown age and gender. Information regarding the patients' pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On an unknown date, the patient was vaccinated with an improperly stored dose of VAQTA (anatomical route of vaccination, lot number and expiration date were not provided) for prophylaxis.        It was reported that, VAQTA, was stored to a temperature of 1 °C for 12 hours. Data logger was involved. Furthermore, it was reported that no adverse effects occurred and that no product quality issue was involved. Additional information has been requested.; Sender's Comments: US-009507513-1705USA002381: US-009507513-1705USA002380: US-009507513-1705USA002383: US-009507513-1705USA002382: US-009507513-1705USA001712:
Pt was a nonresponder to complete series of Engerix-B given on DEC89, 15JAN90 & 27JUL90. Outcome of 2 addt'l doses unk.
I experienced COVID-19 after my vaccine. I had a sore throat, muscle aches, exhaustion for one day and a half. I was prescribed Paxlovid and took the full course. I took two home COVID-19 tests and both were negative. I then went to get a PCR test and it was positive.  I have completely recovered from my symptoms.
Patient was given flu shot at approx. 1405pm on 10/27/08. 15 to 20 minutes later, he complained of itching and hives to his back. He took a Benadryl shortly after noticing the hives which stopped the itching. Hives persisted, and at  15:57, he sought treatment in the Emergency Room at Hospital.
Large area of erythema and induration at injection site. Flu-like sx for 4 days after vaccination. At 6 wk after injection, continues to have hyperpigmentation, increased, warmth and 2x2 cm induration at site.
PT HAD LARGE WELT AND BRUISE AND WELL AS PAIN THAT RADIATES ACCROSS HER UPPER BACK
Left arm was red, swollen and bumps started 7-2-2010 approximately 10A.M. Continued redness, puffiness and bumps on Saturday. Started cold compresses on Saturday. No pain. No TYLENOL or Ibuprofen. Much better on Sunday. Redness gone 7/6/2010. * More behind arm.
Discharge Provider: Private MD. Primary Care Provider at Discharge: Private MD. Admission Date: 8/21/2022- Discharge Date: 8/26/2022. PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1]. HOSPITAL COURSE: Patient is an 81 year old man who presented with profound weakness and fever with recent sick contacts. He was found to be Covid-19 +. He had mild AMS and chronic cognitive deficits. He has been vaccinated and received one booster. He had a normal CTH and CXR. He was treated supportively. He was seen by PT who recommended subacute rehab. Referrals were made by care management, with patient placed at local facility, where he can be treated with PT and OT despite his positive COVID test. Despite his positive COVID test, the patient remained stable, with good oral intake, afebrile without hypoxia. Patient does have a history of cognitive dysfunction. Patient's daughter reports that despite his cognitive dysfunction he had continue to drive. The patient's daughter reported that her mother was becoming exhausted caring for him, as he got up frequently at night. Currently it is unclear if the patient will be able to return to home after subacute rehab. As patient is clinically stable, he was discharged to local skilled Nursing on 08/26/2022.
Patient developed severe chest pain 2-3 days after getting vaccinated. He did not have any other symptoms. Troponins were elevated on admission to the hospital but trending down. His echocardiogram and EKG were normal. He was treated with motrin and discharged home.
2x1 cm area of erythema and dimpling of skin noted on R arm at site of vaccine injection.  Local skin atrophy.  This appeared 2-3 day of vaccines were given, no pain, no treatment given, observation done.
This spontaneous report was received from a female pharmacist of unknown age reporting on herself. The pharmacist was vaccinated with, 0.65 ml ZOSTAVAX, SC in November or December 2012 (lot # and site of administration not reported). No other co-suspects were reported. No concomitant medications were reported. Subsequently, in November or December 2012, the pharmacist experienced red raised area at the injection site that lasted about a week. No treatment was given. The pharmacist did not seek medical attention. It was also reported that the therapy was not reintroduced. The outcome of red raised area at the injection site was reported as recovered/resolved. The relatedness for red raised area at the injection site was not reported for ZOSTAVAX. This is one of several reports from the same source. Additional information is not expected.
Information has been received from a registered nurse (RN) concerning a 55-year-old female with allergies to prochlorperazine maleate (COMPAZINE) and nickel who on 18-DEC-2007 was vaccinated subcutaneously in the left arm with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (lot# 656279/1503F). Concomitant therapy included levothyroxine Na (SYNTHROID), atorvastatin calcium (LIPITOR) and zaleplon (SONATA). On 03-JAN-2008 the patient developed a fever, sore throat and itchy rash. The patient called the physician's office and was referred to an unspecified dermatologist who diagnosed the patient with chickenpox. The patient had bumps (red dots) on her back, stomach, face and neck. The patient also reported feeling achy. The patient was prescribed valacyclovir hydrochloride (VALTREX) 1 gm, TID for 10 days. The RN spoke to the patient on 10-JAN-2008 and the patient was "doing better". At the time of the report the patient was recovering. No product quality complaint was involved. Additional information has been received from a registered nurse. Additional concurrent condition includes hyperlipidemia and medical history was reported as thyroid cancer and kidney cancer. Allergic reations were described as prochlorperazine maleate (COMPAZINE) which was associated with seizures and nickel associated with a rash. There was no recent exposures to chickenpox or shingles. It was reported that the vaccination with varicella virus vaccine live (Oka/Merck) was given in the right upper arm not the left arm as previously reported. On 01-JAN-2008 (previously reported as 03-JAN-2008) the patient developed a sore throat, fever, and rash. The rash was described as macule type with distribution "all over". This is a consolidation of two reports concerning the same patient. Additional information has been requested.
Patient had 3 different clots in her left leg and a small-moderate PE for the first time ever, 2 weeks after #2 Pfizer vaccine.